BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28186686)

  • 1. Combined Bone Marrow-Derived Mesenchymal Stromal Cell Therapy and One-Way Endobronchial Valve Placement in Patients with Pulmonary Emphysema: A Phase I Clinical Trial.
    de Oliveira HG; Cruz FF; Antunes MA; de Macedo Neto AV; Oliveira GA; Svartman FM; Borgonovo T; Rebelatto CL; Weiss DJ; Brofman PR; Morales MM; Lapa E Silva JR; Rocco PR
    Stem Cells Transl Med; 2017 Mar; 6(3):962-969. PubMed ID: 28186686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).
    Kemp SV; Slebos DJ; Kirk A; Kornaszewska M; Carron K; Ek L; Broman G; Hillerdal G; Mal H; Pison C; Briault A; Downer N; Darwiche K; Rao J; Hübner RH; Ruwwe-Glosenkamp C; Trosini-Desert V; Eberhardt R; Herth FJ; Derom E; Malfait T; Shah PL; Garner JL; Ten Hacken NH; Fallouh H; Leroy S; Marquette CH;
    Am J Respir Crit Care Med; 2017 Dec; 196(12):1535-1543. PubMed ID: 28885054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cell therapy in COPD: from bench to bedside.
    Antunes MA; Lapa E Silva JR; Rocco PR
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3017-3027. PubMed ID: 29081655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
    Weiss DJ; Casaburi R; Flannery R; LeRoux-Williams M; Tashkin DP
    Chest; 2013 Jun; 143(6):1590-1598. PubMed ID: 23172272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study.
    Le Thi Bich P; Nguyen Thi H; Dang Ngo Chau H; Phan Van T; Do Q; Dong Khac H; Le Van D; Nguyen Huy L; Mai Cong K; Ta Ba T; Do Minh T; Vu Bich N; Truong Chau N; Van Pham P
    Stem Cell Res Ther; 2020 Feb; 11(1):60. PubMed ID: 32054512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema.
    Stolk J; Broekman W; Mauad T; Zwaginga JJ; Roelofs H; Fibbe WE; Oostendorp J; Bajema I; Versteegh MI; Taube C; Hiemstra PS
    QJM; 2016 May; 109(5):331-6. PubMed ID: 26819296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.
    Weiss DJ; Segal K; Casaburi R; Hayes J; Tashkin D
    Respir Res; 2021 May; 22(1):142. PubMed ID: 33964910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration® Valve System in the Treatment of Severe Emphysema.
    Li S; Wang G; Wang C; Gao X; Jin F; Yang H; Han B; Zhou R; Chen C; Chen L; Bai C; Shen H; Herth FJF; Zhong N
    Respiration; 2019; 97(5):416-427. PubMed ID: 30554211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study of endobronchial valves for advanced emphysema.
    Sciurba FC; Ernst A; Herth FJ; Strange C; Criner GJ; Marquette CH; Kovitz KL; Chiacchierini RP; Goldin J; McLennan G;
    N Engl J Med; 2010 Sep; 363(13):1233-44. PubMed ID: 20860505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When Treatment of Pulmonary Emphysema with Endobronchial Valves Did Not Work: Evaluation of Quantitative CT Analysis and Pulmonary Function Tests Before and After Valve Explantation.
    Leppig JA; Song L; Voigt DC; Feldhaus FW; Ruwwe-Gloesenkamp C; Saccomanno J; Lassen-Schmidt BC; Neumann K; Leitner K; Hubner RH; Doellinger F
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2553-2566. PubMed ID: 36304970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).
    Criner GJ; Sue R; Wright S; Dransfield M; Rivas-Perez H; Wiese T; Sciurba FC; Shah PL; Wahidi MM; de Oliveira HG; Morrissey B; Cardoso PFG; Hays S; Majid A; Pastis N; Kopas L; Vollenweider M; McFadden PM; Machuzak M; Hsia DW; Sung A; Jarad N; Kornaszewska M; Hazelrigg S; Krishna G; Armstrong B; Shargill NS; Slebos DJ;
    Am J Respir Crit Care Med; 2018 Nov; 198(9):1151-1164. PubMed ID: 29787288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of one versus two doses of mesenchymal stromal cells on lung and cardiovascular repair in experimental emphysema.
    Poggio HA; Antunes MA; Rocha NN; Kitoko JZ; Morales MM; Olsen PC; Lopes-Pacheco M; Cruz FF; Rocco PRM
    Stem Cell Res Ther; 2018 Nov; 9(1):296. PubMed ID: 30409216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema.
    Argula RG; Strange C; Ramakrishnan V; Goldin J
    Chest; 2013 Nov; 144(5):1578-1586. PubMed ID: 23828481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study.
    Valipour A; Slebos DJ; Herth F; Darwiche K; Wagner M; Ficker JH; Petermann C; Hubner RH; Stanzel F; Eberhardt R;
    Am J Respir Crit Care Med; 2016 Nov; 194(9):1073-1082. PubMed ID: 27580428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study.
    Chambers DC; Enever D; Lawrence S; Sturm MJ; Herrmann R; Yerkovich S; Musk M; Hopkins PM
    Stem Cells Transl Med; 2017 Apr; 6(4):1152-1157. PubMed ID: 28186707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation.
    Klooster K; ten Hacken NH; Hartman JE; Kerstjens HA; van Rikxoort EM; Slebos DJ
    N Engl J Med; 2015 Dec; 373(24):2325-35. PubMed ID: 26650153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe COPD can benefit from endobronchial valves].
    Riise G; Svanberg T; Samuelsson O
    Lakartidningen; 2019 May; 116():. PubMed ID: 31192398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic Lung Volume Reduction in Relation to Body Mass Index in Patients with Severe Heterogeneous Emphysema.
    Fernandez-Bussy S; Kornafeld A; Labarca G; Abia-Trujillo D; Patel NM; Herth FJF
    Respiration; 2020; 99(6):477-483. PubMed ID: 32492686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stromal Cells to Regenerate Emphysema: On the Horizon?
    Kruk DMLW; Heijink IH; Slebos DJ; Timens W; Ten Hacken NH
    Respiration; 2018; 96(2):148-158. PubMed ID: 29719298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema.
    Eberhardt R; Gompelmann D; Schuhmann M; Reinhardt H; Ernst A; Heussel CP; Herth FJF
    Chest; 2012 Oct; 142(4):900-908. PubMed ID: 22459779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.